Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial

2013; SAGE Publishing; Volume: 7; Issue: 1 Linguagem: Inglês

10.1177/1756283x13503514

ISSN

1756-2848

Autores

Mohamed Emara, Salem Youssef Mohamed, Hesham R. Abdel‐Aziz,

Tópico(s)

Microbial Metabolites in Food Biotechnology

Resumo

The eradication rate of Helicobacter pylori following the standard triple therapy is declining. This study was conducted to test whether the addition of Lactobacillus reuteri to the standard triple therapy improves the eradication rates as well as the clinical and pathological aspects in H. pylori infection.

Referência(s)